Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Virtual Booth

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 EU WC

1 API Suppliers
1 EU WC

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 113-92-8, Chloropheniramine maleate, R-chlorpheniramine maleate, Chlorphenamine maleate,(s), Hms3369f09, Hms3371m22

Molecular Formula

C₂₀H₂₃ClN₂O₄

Molecular Weight

390.9 g/mol

InChI Key

DBAKFASWICGISY-UHFFFAOYSA-N

1 2D Structure

AC1L1QK4

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

but-2-enedioic acid;3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine

2.1.2 InChI

InChI=1S/C16H19ClN2.C4H4O4/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13;5-3(6)1-2-4(7)8/h3-9,11,15H,10,12H2,1-2H3;1-2H,(H,5,6)(H,7,8)

2.1.3 InChI Key

DBAKFASWICGISY-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 113-92-8

2. Chloropheniramine Maleate

3. R-chlorpheniramine Maleate

4. Chlorphenamine Maleate,(s)

5. Hms3369f09

6. Hms3371m22

7. Hms3373a05

8. Hms3393l14

9. Hms3394e15

10. Hms3655g14

11. Bcp09631

12. Akos030228309

13. Sb19136

14. Db-041191

15. Ft-0623712

16. Ft-0665003

17. Ft-0665004

18. Ft-0665005

19. Z2210694610

2.3 Create Date

2005-03-27

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₂₃ClN₂O₄
Molecular Weight	390.9 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	7
Exact Mass	390.1346349 g/mol
Monoisotopic Mass	390.1346349 g/mol
Topological Polar Surface Area	90.7 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	368
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	1
Covalently Bonded Unit Count	2

4 Drug and Medication Information

4.1 Drug Information

1 of 6
Drug Name	HYDROCODONE BITARTRATE AND CHLORPHENIRAMINE MALEATE
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
Company	ACELLA PHARMS LLC (Application Number: A206891)

2 of 6
Drug Name	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Company	PADDOCK LLC (Application Number: A204627)

3 of 6
Drug Name	VITUZ
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE
Company	CYPRESS PHARM (Application Number: N204307)

4 of 6
Drug Name	HYDROCODONE BITARTRATE, CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Company	BIO-PHARM INC (Application Number: A206660)

5 of 6
Drug Name	HYDROCODONE BITARTRATE,CHLORPHENIRAMINE MALEATE AND PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Company	MAYNE PHARMA INC (Application Number: A205657)

6 of 6
Drug Name	ZUTRIPRO
Active Ingredient	CHLORPHENIRAMINE MALEATE; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE
Company	CYPRESS PHARM (Application Number: N022439)